Postoperative adjuvant therapy

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 18, Issue 6, 2011, Pages 792-796

  Kosuge, Tomoo ^a   Sakamoto, Yoshihiro ^a   Ueno, Hideki ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Adjuvant therapy; Chemotherapy; Pancreatic cancer

Indexed keywords

CAPECITABINE; CISPLATIN; DOXORUBICIN; ERLOTINIB; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; MITOMYCIN C;

ADJUVANT THERAPY; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COLORECTAL CANCER; DIARRHEA; DISEASE FREE SURVIVAL; HUMAN; LIVER TOXICITY; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PANCREATICODUODENECTOMY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PERIOD; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; STOMACH CANCER; STOMATITIS; STUDY DESIGN; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT PLANNING; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 80255136303     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-011-0433-2     Document Type: Article

References (17)

1. MD Lieberman H Kilburn M Lindsey MF Brennan 1995 Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy Ann Surg 222 638 645 7487211 10.1097/00000658- 199511000-00006 1:STN:280:DyaK28%2Fms12rsg%3D%3D
2. TA Sohn CJ Yeo JL Cameron L Koniaris S Kaushal RA Abrams, et al. 2000 Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 567 579 11307091 10.1016/S1091-255X(00)80105-5 1:STN:280:DC%2BD3Mzlt1yqtA%3D%3D
3. K Shimada Y Sakamoto T Sano T Kosuge N Hiraoka 2006 Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma Pancreas 33 233 239 17003643 10.1097/01.mpa.0000232917.78890.01 (Pubitemid 44470137)
4. CG Moertel DS Childs Jr RJ Reitemeier MY Colby Jr MA Holbrook 1969 Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer Lancet 294 865 867 10.1016/S0140-6736(69) 92326-5
5. MH Kalser SS Ellenberg 1985 Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 899 903 4015380 1:STN:280:DyaL2M3ltFSnsQ%3D%3D (Pubitemid 15040883)
6. JH Klinkenbijl J Jeekel T Sahmoud R van Pel ML Couvreur CH Veenhof, et al. 1999 Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg 230 776 782 10615932 10.1097/00000658-199912000-00006 1:STN:280:DC%2BD3c%2FotFKkug%3D%3D (Pubitemid 30191812)
7. KE Bakkevold B Arnesjø O Dahl B Kambestad 1993 Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective, randomised multicentre study Eur J Cancer 29A 698 703 8471327 10.1016/S0959-8049(05)80349-1 1:STN:280:DyaK3s3ivFWhtQ%3D%3D (Pubitemid 23077048)
8. T Takada H Amano H Yasuda Y Nimura T Matsushiro H Kato, et al. 2002 Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma Cancer 95 1685 1695 12365016 10.1002/cncr.10831
9. T Kosuge T Kiuchi K Mukai T Kakizoe 2006 Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP). A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer Jpn J Clin Oncol 36 159 165 16490736 10.1093/jjco/hyi234
10. JP Neoptolemos DD Stocken H Friess C Bassi JA Dunn H Hickey, et al. 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200 1210 15028824 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D (Pubitemid 38339364)
11. H Oettle S Post P Neuhaus K Gellert J Langrehr K Ridwelski, et al. 2007 Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 267 277 17227978 10.1001/jama.297.3.267 1:CAS:528: DC%2BD2sXotVCmug%3D%3D (Pubitemid 46143304)
12. Neuhaus P, Riess H, Post K, Gellert K, Ridwelski K, Schramm H et al. CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). Proc Am Soc Clin Oncol. 2008;26:15S (abstract LBA4504).
13. H Ueno T Kosuge Y Matsuyama J Yamamoto A Nakao S Egawa, et al. 2009 A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer Br J Cancer 101 908 915 19690548 10.1038/sj.bjc.6605256 1:CAS:528:DC%2BD1MXhtV2qsrjN
14. JP Neoptolemos DD Stocken C Bassi P Ghaneh D Cunningham D Goldstein, et al. 2010 for the European Study Group for Pancreatic Cancer Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JAMA 304 1073 1081 20823433 10.1001/jama.2010.1275 1:CAS:528:DC%2BC3cXhtFequ7nE
15. WF Regine KA Winter RA Abrams H Safran JP Hoffman A Konski, et al. 2008 Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial JAMA 299 1019 1026 18319412 10.1001/jama.299.9.1019 1:CAS:528:DC%2BD1cXjtVSltL0%3D (Pubitemid 351347058)
16. JL Van Laethem P Hammel F Mornex D Azria G Van Tienhoven P Vergauwe, et al. 2010 Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study J Clin Oncol 28 4450 4456 20837948 10.1200/JCO.2010.30.3446
17. Ishii H, Ueno H, Kosuge T, Matsuyama Y, Saiura A, Nakao A et al. A phase I/II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP-03). Proc Am Soc Clin Oncol. 2010;28:15S (abstract e14625).